Bausch Health Companies (TSE:BHC) Rating Increased to Hold at Evercore ISI

Bausch Health Companies (TSE:BHC) was upgraded by equities research analysts at Evercore ISI to a “hold” rating in a research note issued to investors on Tuesday, Zacks.com reports.

Separately, Raymond James raised shares of Bausch Health Companies to a “hold” rating in a research report on Wednesday, July 10th.

Bausch Health Companies Stock Up 0.8 %

BHC stock opened at C$11.66 on Tuesday. The business has a 50 day moving average of C$9.17 and a 200 day moving average of C$10.00. The firm has a market cap of C$4.28 billion, a PE ratio of -6.66, a price-to-earnings-growth ratio of 0.21 and a beta of 0.77. Bausch Health Companies has a twelve month low of C$5.45 and a twelve month high of C$15.43. The company has a quick ratio of 0.58, a current ratio of 1.19 and a debt-to-equity ratio of 7,583.76.

Bausch Health Companies (TSE:BHC) last announced its quarterly earnings results on Thursday, August 1st. The company reported C$1.22 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of C$1.22. Bausch Health Companies had a negative net margin of 5.12% and a negative return on equity of 2,304.54%. The firm had revenue of C$3.29 billion for the quarter, compared to the consensus estimate of C$3.20 billion. On average, research analysts forecast that Bausch Health Companies will post 5.5472637 EPS for the current fiscal year.

Insider Buying and Selling at Bausch Health Companies

In other Bausch Health Companies news, Senior Officer Seana Lynne Carson sold 13,370 shares of the stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of C$8.38, for a total value of C$112,087.40. Corporate insiders own 11.28% of the company’s stock.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.